News search

E.g., 08/01/2026
E.g., 08/01/2026
Héctor Bueno JACARDI
About the CNIC
15 Dec 2025

A new policy paper highlights key areas for advancing data-driven policymaking to curb the rising burden of non-communicable diseases (NCDs), setting the stage for a more effective and equitable healthcare in Europe 

Investigadores del "The Placenta in Maternal and Fetal Cardiovascular Health and Disease” reunidos en el CNIC
JACARDI_Madrid
About the CNIC
20 Oct 2025

The Spanish National Center for Cardiovascular Research (CNIC) hosted in Madrid the third General Assembly of JACARDI from October 14 to 16 

Jorge Alegre-Cebollada
About the CNIC
25 Sep 2025

Dr. Alegre-Cebollada will be recognized for the pioneering the study of protein mechanics in living systems, revealing how mechanical forces govern protein function and contribute to human disease.

José Luis de la Pompa, Blanca Rubio, Rocío Serrano, Laura Lalaguna, Pablo García Pavía, María López Olañeta y Enrique Lara.
Research
10 Sep 2025

The results, published in the European Heart Journal and presented at the European Society of Cardiology Congress, opens the way to new therapies for patients with genetic heart diseases

El investigador del Centro Nacional de Investigaciones Cardiovasculares (CNIC) y del Servicio de Cardiología del Hospital Universitario 12 de Octubre, Héctor Bueno
Research
4 Sep 2025

ESC calls for a cultural shift to deal with the adverse combination of mental health conditions and cardiovascular disease

Pablo García-Pavía, Nerea Mora Ayestarán y Fernando Domínguez
Research
3 Sep 2025

Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), together with cardiologists from Hospital Universitario Puerta de Hierro and the Spanish cardiovascular disease research network (CIBERCV), report that the new discovery makes it possible to identify high-risk patients early and refer them sooner to specialized heart failure units

La investigadora Claudia Monaco
Research
1 Aug 2025

Dr. Claudia Monaco, Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK

image
Research
16 Jul 2025

A new study led by the CNIC has identified imidazole propionate (ImP), a metabolite produced by gut bacteria, as a driver of atherosclerosis— as a driver of atherosclerosis, the disease behind most heart attacks and strokes